Cancure’s scientific vision is guided by Professor Stephen Ralph and Professor Jiri Neuzil, world leaders in immunology and mitochondrial biology respectively. Professors Ralph and Neuzil have published extensively, with decades of research conducted at Monash University in Melbourne and Griffith University on the Gold Coast.
Statistics indicate that 50% of all people will be diagnosed with cancer at some point in their lives, and 25% of all people will suffer an undignified and agonising death from this dreadful disease. The company’s co-founders and committed investors are personally driven to combat cancer – and they have committed their lives and significant resources to find a cure.
Cancure’s suite of breakthrough therapies has the potential to make a pivotal contribution in the fight against cancer.